Flu Vaccine Access Via Pharmacy Vaccine Network

Similar documents
Immunization Update 2016 Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH

Talkin Flu Mid-America Immunization Coalition August 18, William Atkinson, MD, MPH Immunization Action Coalition

MA Adult Immunization Coaltion Flu Update September 28, 2016

Hemagglutinin Neuraminidase

Immunization Update Tamara Sheffield, MD, MPA, MPH

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.

Influenza Update. Lisa Grohskopf, MD, MPH Influenza Division, CDC. NAICP Call 6 October 2015

CONTAGIOUS COMMENTS Department of Epidemiology

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.

MDPH Influenza Update

New Reminder Alerts added to Online Member Health Records

New Vaccine Schedules. Disclosure. Overview. Immunization Recommendations in Primary Care. Objectives Pharmacists. Objectives Pharmacy Technicians

Immunization Update 2017 Peds Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH

HIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS. Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan

Adult Immunization Update 2015

Benefit Interpretation

2017 Immunization Update for Pharmacy Professionals

Immunization Update 2017 Adult Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH

Immunizations: An Overview. Sutter Health May 9, 2017 John Apostolo, PharmD, MBA Heidi Rens, PharmD

Needle Facts: Immunization Update 2016

Needle Facts: Immunization Update Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy

Adult Immunization Update 2017 Including Influenza General Best Practice Guidelines for Immunization

Influenza Prevention Update

Update on Influenza Vaccines, the Influenza Season, and the Impact of Vaccination on Influenza Disease Burden

Advisory Committee on Immunization Practices Meeting Update

07/20/17, 05/17/18 CATEGORY: Vaccines/Biologics. Proprietary Information of Excellus Health Plan, Inc.

FDA Approved Recombinant Hemagglutinin Influenza Vaccine Protects Against Drift Influenza Viruses

Cigna Drug and Biologic Coverage Policy

Diclosures. Objectives 12/29/17

Adult Immunization, Patient-Centered Medical Care, and the Primary Physician

Hot off the press, What s new for immunizations in 2017?

9/11/2018. Influenza and Influenza Vaccines. Influenza. Influenza Virus. Highly infectious viral illness. First pandemic in 1580

9/22/2016. Disclosure / Conflict of Interest. Learning Objectives: Pharmacists. Testing Your Knowledge. Learning Objectives: Pharmacy Technicians

Kenneth McCall, BSPharm, PharmD Associate Professor UNE President Maine Pharmacy Association

Health Care Personnel Vaccination in the Long Term Care Setting

Needle Facts: Immunization Update 2017

Immunization Update. William Atkinson, MD, MPH. Immunization Action Coalition

Update on Adult Immunization

These slides are the property of the presenter. Do not duplicate without express written consent.

National Immunization Update

National Immunization Update

Influenza: Wrap- Up and Preview of the Upcoming Season. October 6, 2016 Anita Valiani, MPH

Disclosures. No support One off-label recommendation

ACCREDITATION Pharmacy

Immunization Update: What s New in 2013? Thursday, August 15, :30 a.m. 12:30 p.m.

Vaccine Update for the Pharmacist

Slide 1. Slide 2 Disclosure. Slide 3 Learning Objectives

INFLUENZA UPDATE MCAAP Webinar Susan M. Lett, MD, MPH Medical Director, Immunization Program MA Department of Public Health

Influenza Clinical Bulletin # 3: October 8, 2009 Vaccination Guidelines for Patients for Influenza

Q2034 And The New Flu Shot Medicare Reimbursement Codes

Annual Influenza Review

Immunization Update 2017

Kenneth McCall, BSPharm, PharmD Associate Professor UNE

9/12/2018. Influenza and Influenza Vaccines. Influenza. Influenza Virus. Highly infectious viral illness. First pandemic in 1580

CPT 2016 Code Changes

Flu Vaccines for

The Omnicare HealthLine

Immunization Update 2013 Across the Lifespan

Nothing to disclose. Vaccinations for Adults and Adolescents: An Update. Key Resource

The Advisory Committee on Immunization

What You Need to Know About the Flu

Making Life Better UNIVERSITY OF SOUTH FLORIDA

WEBINAR 1 CODING FOR FLUZONE VACCINATION CODING AND BILLING FOR VACCINATION WITH FLUZONE, INFLUENZA VACCINES CRACKING THE CODES: UPDATED for

NC IMMUNIZATION COALITION FLU THEN AND NOW NC DHHS COMMUNICABLE DISEASE BRANCH ANITA VALIANI, MPH AUGUST 1, 2018

Coverage of Vaccines Medicaid and Child Health Plus Members

Influenza: A recap of the season

Transforming The Approach to Vaccines and Protein- Based Therapeutics. Alain Doucet, Ph.D. Manager, Process Development, Medicago

Immunization Update Disclosures. Candice Robinson, MD, MPH Medical Officer Immunization Services Division 5/12/2017

10/12/2016. Disclosures. Immunization Update Disclosures

Immunization Update 2013

Nothing to disclose. Influenza Update. Influenza Biology. Influenza Biology. Influenza A 12/15/2014

Should patients with diabetes receive an influenza vaccine yearly?

Adult Vaccines in 2018: Where do we start?

IMMUNIZATION UPDATE: 2015 Patti Fabel, PharmD Clinical Assistant Professor SC College of Pharmacy USC Campus

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10 13, 2016

Recommendations for Prevention and Control of Influenza in Children, COMMITTEE ON INFECTIOUS DISEASES

HIT ME WITH YOUR BEST SHOT: UPDATE ON IMMUNIZATIONS. Karen Hoang, PharmD Clinical Pharmacy Specialist, MTM Services UPMC Health Plan

Influenza Vaccines: Giving the Right Dose at the Right Time. Agenda

The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California

Preventing Infections

Influenza. Alan P. Agins, Ph.D Objectives. Influenza Update: Influenza. Disclosures. Influenza Virus.

Vaccinations: What are the recommendations. Disclaimer 03/19/2019. Harold J. Manley, PharmD, FCCP, FASN Senior Pharmacy Director Dialysis Clinic, Inc.

The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California

TRICARE Retail Vaccination Program Vaccine List - September 2018*

ACIP Meeting Update, New Recommendations and Pending Influenza Season

Update on Adult Immunization Strategies: Understanding the Current Recommendations

Immunization Update 2015

Guidelines for Vaccinating Pregnant Women

Andrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010

Navigating Options for Influenza Immunization, What a difference a decade makes 2004

Disclosures. Potential conflicts. No off-label use discussion. Safety Review Committee. Data and Safety Monitoring Board

Vaccine Label Examples

Seasonal Influenza Report

Immunization Update 2018

ACIP Meeting June 22, 2016 Influenza Session: Key Points

Child Health and Disability Prevention (CHDP) Program Code Conversion

Vaccine Label Examples

Update ACIP Influenza Vaccination Recommendations for

Transcription:

Re: Flu Vaccine Access Via Pharmacy Vaccine Network Effective 9/15/2016, IEHP Medi-Cal and Medicare DualChoice Cal MediConnect (IEHP Direct) Members who are over 18 years old may obtain Flu Vaccines through the IEHP Pharmacy Vaccine Network. Please note that Members under 18 years old must obtain VFC-covered vaccines through their PCP s office. There is no contracted Pharmacy able to provide VFC-covered vaccines currently. Pharmacy Vaccine Network listing is available through our website at https://ww3.iehp.org/en/members/find-a-doctor/ (under IEHP Find a Doctor, Urgent Care or Pharmacy Webpage) Dear IEHP Provider: On August 26, 2016, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) published the updated recommendations regarding the use of influenza vaccine for the 2016-2017 influenza season. The primary changes and updated recommendations are as follows: For 2016 17, ACIP recommends the following: Routine annual influenza vaccination of all persons aged 6 months without contraindications continues to be recommended. No preferential recommendation is made for one influenza vaccine product over another for persons for whom more than one licensed, recommended product is otherwise appropriate. In light of low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013 14 and 2015 16 seasons, for the 2016 17 season, ACIP makes the interim recommendation that LAIV4 should not be used. Because LAIV4 is still a licensed vaccine that might be available and that some providers might elect to use, for informational purposes, reference is made to previous recommendations for its use. P.O. Box 19026, San Bernardino, CA 92423-9026

Page 2 of 8 2016 17 U.S. trivalent influenza vaccines will contain an A/California/7/2009 (H1N1) like virus, an A/Hong Kong/4801/2014 (H3N2) like virus and a B/Brisbane/60/2008 like virus (Victoria lineage). Quadrivalent vaccines will include an additional vaccine virus strain, a B/Phuket/3073/2013 like virus (Yamagata lineage). Recent new vaccine licensures are discussed: o o An MF59-adjuvanted trivalent inactivated influenza vaccine (aiiv3), Fluad (Seqirus, Holly Springs, North Carolina), was licensed by FDA in November 2015 for persons aged 65 years. Regulatory information is available at http://www.fda.gov/biologicsbloodvaccines/safetyavailability/vaccinesafety/ucm47398 9.htm. aiiv3 is an acceptable alternative to other vaccines licensed for persons in this age group. ACIP and CDC do not express a preference for any particular vaccine product. A quadrivalent formulation of Flucelvax (cell culture-based inactivated influenza vaccine [cciiv4], Seqirus, Holly Springs, North Carolina) was licensed by FDA in May 2016, for persons aged 4 years. Regulatory information is available at: http://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm502844.ht m. cciiv4 is an acceptable alternative to other vaccines licensed for persons in this age group. No preference is expressed for any particular vaccine product. Recommendations for influenza vaccination of persons with egg allergy have been modified, including: o Removal of the recommendation that egg-allergic recipients should be observed for 30 minutes post vaccination for signs and symptoms of an allergic reaction. Providers should consider observing all patients for 15 minutes after vaccination to decrease the risk for injury should they experience syncope, per the ACIP General Recommendations on Immunization. o A recommendation that persons with a history of severe allergic reaction to egg (i.e., any symptom other than hives) should be vaccinated in an inpatient or outpatient medical setting (including but not necessarily limited to hospitals, clinics, health departments, and physician offices), under the supervision of a health care provider who is able to recognize and manage severe allergic conditions.

Page 3 of 8 Vaccine Coverage VFC covered vaccines VFC (Vaccines for Children)-eligible children who are aged 6 months through 18 years should receive influenza vaccination through VFC program. IEHP Medi-Cal (Over 18 years old) and Medicare DualChoice Cal MediConnect Plan (Medicare- Medicaid Plan) IEHP will reimburse Providers the cost of the vaccine for IEHP Medi-Cal (over 18 years old) and Medicare DualChoice Cal MediConnect Members (IEHP Direct Members) by line of business (Medi-Cal / Medicare Rate). Submit your completed CMS1500 claim form with the correct CPT code to IEHP Claims Dept., P.O. Box 4349, Rancho Cucamonga, CA 91729-4349. Flu vaccine coverage Codes Description IEHP Medi-Cal under 18 Years of Age IEHP Medi- Cal Adult Members IEHP Medicare DualChoice- IEHP Direct 90630 (IIV4), split virus, preservative free, for intradermal use Ages 18-64 only FLUZONE INTRADERMAL QUADRIVALENT 90654 (IIV3), split virus, preservative free, for intradermal use Ages 18-64 only FLUZONE INTRADERMAL 90655 (IIV3), split virus, preservative free, for children 6-35 months of age, for VFC

Page 4 of 8 FLUZONE PEDIATRIC 90656 (IIV3), split virus, preservative free, for use in individuals 3 years and above, for AFLURIA, FLUZONE, FLUARIX, FLUVIRIN, EZ Flu VFC 90657 (IIV3), split virus, for children 6-35 months of age, for FLUZONE VFC 90658 (IIV3), split virus, for use inindividuals 3 years of age and above, for BN: FLUZONE, FLUVIRIN, AFLURIA, FLULAVAL VFC Not covered; use a vaccinespecific Q code. 90660 (LAIV3), live, for intranasal use Ages 2-49 years only Product no longer available BN: FLUMIST 90661 Influenza virus vaccine (cciiv3), derived from cell cultures, subunit, preservative and antibiotic free, for Ages 18-99 only

Page 5 of 8 FLUCELVAX 90662 Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for Ages 65 & older only FLUZONE HIGH DOSE 90672, live (LAIV4), for intranasal use Ages 2-49 only Not covered Not covered Not covered FLUMIST QUADRIVALENT 90673 (RIV3), derived from recombinant DNA (RIV3), hemagglutinin (HA) protein only, preservative and antibiotic free, for Ages 18-49 only FLUBLOK 90685 (IIV4), split virus, preservative free, when administered to children 6-35 months of age, for Ages 6-35 months only VFC FLUZONE QUADRIVALENT 90686 (IIV4), split virus, preservative free, when administered to individuals 3 years of age and older, for VFC

Page 6 of 8 Ages 3-99 years only FLUZONE QUADRIVALENT, FLUARIX QUADRIVALENT 90687 (IIV4), split virus, when administered to children 6-35 months of age, for Ages 3-35 months only FLUZONE QUADRIVALENT VFC 90688 (IIV4), split virus, preservative free, when administered to individuals 3 years of age and older, for Ages 3-99 years only VFC FLULAVAL QUADRIVALENT, FLUZONE QUADRIVALENT Q2034 Agriflu influenza virus vaccine, split virus, for,ages 18-99 years only AGRIFLU Q2035 Afluria influenza virus vaccine, split virus, for use in individuals 3 years of age and above, for AFLURIA Q2036 Flulaval influenza virus vaccine, split virus, for use in individuals 3 years of age and above, for

Page 7 of 8 FLULAVAL Q2037 Fluvirin influenza virus vaccine, split virus, for use in individuals 3 years of age and above, for FLUVIRIN Q2038 Fluzone influenza virus vaccine, split virus, for use in individuals 3 years of age and older, for FLUZONE, FLUZONE PEDIATRIC, FLUZONE HIGH DOSE Q2039 Influenza virus vaccine, split virus, when administered toindividuals 3 years of age and older, for (not otherwise specified) FLUZONE HIGH DOSE, FLUARIX ***NEW Expanded Adult Vaccines at IEHP Pharmacy Vaccine Network*** Starting in September 2016, IEHP Medi-Cal or Medicare Members may receive ACIP recommended Adult Vaccines through our Pharmacy Vaccine Network, including but not limited to: 1. Influenza 2. Td/Tdap 3. Varicella 4. HPV 5. Zoster 6. MMR 7. PCV13 8. PPSV23 9. Hepatitis A/B 10. MPSV4 11. Hib 12. MenB

Page 8 of 8 Please note that Members under 18 years old must obtain VFC-covered vaccines through their PCP s office. There is no contracted Pharmacy able to provide VFC-covered vaccines currently. Vaccine coverage by location Location IEHP Medi-Cal under 18 Years of Age IEHP Medi-Cal Adult Members IEHP Medicare DualChoice (IEHP Direct Members) Physician office VFC VFC restrictions apply Pharmacies that participate in the IEHP Pharmacy Vaccine Network Not Available Via IEHP Medi-Cal Pharmacy Vaccine Network Available for Members over 18 Years old Via IEHP Medicare Pharmacy Vaccine Network Available for Members over 18 Years old It is important to know that the availability of Adult vaccines varies by Pharmacies. If Physician is referring an IEHP Members to one of our Pharmacy Vaccine Network Provider to receive immunization, please refer to our Pharmacy Vaccine Network list and advise the Member to call the pharmacy in advance for scheduling and availability of the vaccine. Although a prescription is not necessary, it is also advised that you provide a prescription in case if the pharmacy lacks a protocol to initiate a prescription. Should you have any questions regarding the above, please call us at (909) 890-2067. Sincerely, Jennifer Sayles, M.D. MPH Chief Medical Officer Inland Empire Health Plan